Archives of Pediatric Infectious Diseases

Published by: Kowsar

The History of Tuberculosis and Bacillus Calmette–Guérin Vaccine in Iran

Fatemeh Fallah 1 and Hamed Abdolghafoorian 1 , *
Authors Information
1 Pediatric Infections Research Center, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Pediatric Infectious Diseases: January 2015, 3 (1 TB); e59840
  • Published Online: January 13, 2015
  • Article Type: Review Article
  • Received: May 28, 2014
  • Accepted: June 9, 2014
  • DOI: 10.5812/pedinfect.20766

To Cite: Fallah F, Abdolghafoorian H. The History of Tuberculosis and Bacillus Calmette–Guérin Vaccine in Iran, Arch Pediatr Infect Dis. 2015 ; 3(1 TB):e59840. doi: 10.5812/pedinfect.20766.

Copyright © 2015, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Rafiee S, Besharat S, Jabbari A, Golalipour F, Nasermoaadeli A. Epidemiology of tuberculosis in northeast of Iran: a population-based study. Iran J Med Sci. 2009; 34(3): 193-7
  • 2. Alimagham M, Aminiafshar S, Farahmand S, Vahdani P, Alavi Moghadam M, Sharafi K. BCG Vaccination and Active Tuberculosis Prevention: A Three-Year Study. Tanaffos. 2007; 6(2): 63-7
  • 3. Cayabyab MJ, Macovei L, Campos Neto A. Current and novel approaches to vaccine development against tuberculosis. Front Cell Infect Microbiol. 2012; 2: 154[DOI][PubMed]
  • 4. Rabban Tabari A. Firdous al-Hekmah (Paradise of Wisdom). 1928;
  • 5. Razi AMZ. [Ghesas and Hekayat-e al-Marazi (33 Clinical Observations)].Translated by Najamabadi. 1978;
  • 6. Najmabadi M. [Tarikh-e Tebb dar Iran pas Az Islam (History of Medicine in Iran after Islam)]. 2000;
  • 7. Avicenna . [The Canon of Medicine]. Translated by Sharafkandi . 1991;
  • 8. Zari Z. A History of Tuberculosis. 2004;
  • 9. Islami Jorjani I. [Zakhire-ye Kharazmshahi]. Edited by Mohhareri. Acad Med Sci Iran. 2002; 1(163)
  • 10. Caminero JA. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding. Int J Tuberc Lung Dis. 2010; 14(4): 382-90[PubMed]
  • 11. Metanat M, Sharifi-Mood B, Shahreki S, Dawoudi SH. Prevalence of multidrug-resistant and extensively drug-resistant tuberculosis in patients with pulmonary tuberculosis in zahedan, southeastern iran. Iran Red Crescent Med J. 2012; 14(1): 53-5[PubMed]
  • 12. Rook GA, Dheda K, Zumla A. Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat Rev Immunol. 2005; 5(8): 661-7[DOI][PubMed]
  • 13. Lambert PH, Hawkridge T, Hanekom WA. New vaccines against tuberculosis. Clin Chest Med. 2009; 30(4): 811-26[DOI][PubMed]
  • 14. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA. 1994; 271(9): 698-702[PubMed]
  • 15. Abebe F, Bjune G. The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guerin (BCG) vaccines: is there a link? Clin Exp Immunol. 2006; 145(3): 389-97[DOI][PubMed]
  • 16. Hiraishi Y, Nandakumar S, Choi SO, Lee JW, Kim YC, Posey JE, et al. Bacillus Calmette-Guerin vaccination using a microneedle patch. Vaccine. 2011; 29(14): 2626-36[DOI][PubMed]
  • 17. Harrison's Principles of Internal Medicine vol 1. 2001;
  • 18. Svenson S, Kallenius G, Pawlowski A, Hamasur B. Towards new tuberculosis vaccines. Hum Vaccin. 2010; 6(4): 309-17[PubMed]
  • 19. Henao-Tamayo MI, Ordway DJ, Irwin SM, Shang S, Shanley C, Orme IM. Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis. Clin Vaccine Immunol. 2010; 17(4): 618-25[DOI][PubMed]
  • 20. Nambiar JK, Pinto R, Aguilo JI, Takatsu K, Martin C, Britton WJ, et al. Protective immunity afforded by attenuated, PhoP-deficient Mycobacterium tuberculosis is associated with sustained generation of CD4+ T-cell memory. Eur J Immunol. 2012; 42(2): 385-92[DOI][PubMed]
  • 21. Rook GA, Dheda K, Zumla A. Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting? Vaccine. 2005; 23(17-18): 2115-20[DOI][PubMed]
  • 22. Dheda K, Chang JS, Breen RA, Kim LU, Haddock JA, Huggett JF, et al. In vivo and in vitro studies of a novel cytokine, interleukin 4delta2, in pulmonary tuberculosis. Am J Respir Crit Care Med. 2005; 172(4): 501-8[DOI][PubMed]
  • 23. Andersen P, Doherty TM. The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat Rev Microbiol. 2005; 3(8): 656-62[DOI][PubMed]
  • 24. Ordway DJ, Shang S, Henao-Tamayo M, Obregon-Henao A, Nold L, Caraway M, et al. Mycobacterium bovis BCG-mediated protection against W-Beijing strains of Mycobacterium tuberculosis is diminished concomitant with the emergence of regulatory T cells. Clin Vaccine Immunol. 2011; 18(9): 1527-35[DOI][PubMed]
  • 25. Floor W. Public Health in Qajar Iran. 2004;
  • 26. Polak JE. [Iran and Iranians (Persien, das Land und seine)]. Translated by Jahandari. 1989;
  • 27. Ghodssi M. [The History of the Fifty Years of the Services of the Pasteur Institute of Iran]. Pasteur Inst Iran. 1971; 15
  • 28. The History of the Establishment of Dr. Masih Daneshvari Hospital. 2010;
  • 29. The Agenda of the Society against TB and the Support of TB Patients (Anjoman-e Mobarez-e ba Sel va Hemayat Az Masloulin). National Library and Archives of the I.R. of Iran 1944;
  • 30. Abbasi-Dezfouli A, Daneshvar-Kakhki A, Arab M, Javaherzadeh M, Shadmehr MB, Abbasi S, et al. Development of thoracic surgery in Iran. Arch Iran Med. 2007; 10(4): 547-9[PubMed]
  • 31. Velayati AA. Tuberculosis. 2010;
  • 32. Hatami H. Textbook of Public Health. 2006; 2: 1126-7
  • 33. Nadim A, Azordegan F. [Nemai Amari Vazea Behdasht va Darman Dar Iran, Dar Payan-e Dahahy-e Haftad]. Iran Acad Med Sci. 2004; : 94 – 7
  • 34. The status of TB/HIV Co-infection. Report of the Administration of Tuberculosis and Leprosy Control of the Ministry of Health and Medical Education I.R. Iran. 2011;
  • 35. Alavi SM, Moradzadegan H, Khoshkhoy MM. Seroprevalence of HIV in Newly Detected Pulmonary Tuberculosis Patients in Khuzestan, Iran: Should HIV Testing Be Included in National Tuberculosis Program in This Region? Jundishapur J Microbiol. 2013; 6(2): 193-6
  • 36. Nasiri MJ, Rezaei F, Zamani S, Darban-Sarokhalil D, Fooladi AA, Shojaei H, et al. Drug resistance pattern of Mycobacterium tuberculosis isolates from patients of five provinces of Iran. Asian Pac J Trop Med. 2014; 7(3): 193-6[DOI][PubMed]
  • 37. Liu J, Tran V, Leung AS, Alexander DC, Zhu B. BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy. Hum Vaccin. 2009; 5(2): 70-8[PubMed]
  • 38. Bedwell J, Kairo SK, Behr MA, Bygraves JA. Identification of substrains of BCG vaccine using multiplex PCR. Vaccine. 2001; 19(15-16): 2146-51[PubMed]
  • 39. Markey K, Ho MM, Choudhury B, Seki M, Ju L, Castello-Branco LR, et al. Report of an international collaborative study to evaluate the suitability of multiplex PCR as an identity assay for different sub-strains of BCG vaccine. Vaccine. 2010; 28(43): 6964-9[DOI][PubMed]
  • 40. Magdalena J, Supply P, Locht C. Specific differentiation between Mycobacterium bovis BCG and virulent strains of the Mycobacterium tuberculosis complex. J Clin Microbiol. 1998; 36(9): 2471-6[PubMed]
  • 41. Kearns AM, Magee JG, Gennery A, Steward M, Graham C, Seiders PR, et al. Rapid identification of Mycobacterium bovis BCG by the detection of the RD1 deletion using a multiplex PCR technique. Int J Tuberc Lung Dis. 1999; 3(7): 635-8[PubMed]
  • 42. Kim SH, Kim SY, Eun BW, Yoo WJ, Park KU, Choi EH, et al. BCG osteomyelitis caused by the BCG Tokyo strain and confirmed by molecular method. Vaccine. 2008; 26(34): 4379-81[DOI][PubMed]
  • 43. Brosch R, Gordon SV, Buchrieser C, Pym AS, Garnier T, Cole ST. Comparative genomics uncovers large tandem chromosomal duplications in Mycobacterium bovis BCG Pasteur. Yeast. 2000; 17(2): 111-23[DOI][PubMed]
  • 44. Collins DM, De Lisle GW. BCG identification by DNA restriction fragment patterns. J Gen Microbiol. 1987; 133(6): 1431-4[PubMed]
  • 45. Pourhajibagher M, Nasrollahi M, Ahanjan M. Detection of Mycobacterium tuberculosis complex by gyrB PCR in patients with clinical suspicious of tuberculosis in Mazandaran, Iran. Arch Clin Infect Dis. 2012; 6(3): 104-7
  • 46. Okazaki T, Ebihara S, Takahashi H, Asada M, Sato A, Seki M, et al. Multiplex PCR-identified cutaneous tuberculosis evoked by Mycobacterium bovis BCG vaccination in a healthy baby. J Clin Microbiol. 2005; 43(1): 523-5[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments